Skip to main navigation Skip to search Skip to main content

Role of the adiponectin leptin ratio in prostate cancer

  • Michael E. Grossmann
  • , Nancy K. Mizuno
  • , Melissa J.L. Bonorden
  • , Amitabha Ray
  • , Irina Sokolchik
  • , Meena L. Narasimhan
  • , Margot P. Cleary

Research output: Contribution to journal › Article › peer-review

Abstract

We hypothesize that adiponectin and leptin may be capable of mediating some of the effects that body weight has on prostate cancer and that a mouse model may be effective to examine this hypothesis. We found that tumors from the TRAMP prostate cancer model expressed adiponectin and leptin receptors. TRAMP-C2 prostate cancer cell proliferation was reduced by adiponectin. Leptin was able to block the ability of adiponectin to reduce cell proliferation through altered signaling of the ERK pathway. Overall, this work suggests that adiponectin, leptin, and their receptors may play an important role in prostate cancer.

Original languageEnglish (US)
Pages (from-to)269-277
Number of pages9
JournalOncology Research
Volume18
Issue number5-6
DOIs
StatePublished - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adiponectin
  • Leptin
  • Osmotin
  • Prostate cancer
  • TRAMP mice
  • TRAMP-C2 cells

Fingerprint

Dive into the research topics of 'Role of the adiponectin leptin ratio in prostate cancer'. Together they form a unique fingerprint.

Cite this